Skip to main content
. 2020 Apr 27;27(10):2828–2842. doi: 10.1038/s41418-020-0545-9

Fig. 7. The molecular timer may contribute to treatment resistance in patients with stage III colorectal cancer.

Fig. 7

The cooperative recruitment model (ApoptoCoop) was used to classify 120 patients with stage III colorectal as apoptosis capable or resistant by C3-substrate cleavage after 300 min and was used to draw Kaplan–Meier curves (i) of disease free survival (a) and overall survival (b) and compare hazard ratios against a simplified model of apoptosis (ApoptoCell) (ii). The contribution of the molecular timer, calculated as the difference in C3-substrate cleavage with or without the molecular timer, 5 h post-MOMP in colorectal patients (c). ROC and AUC of the ability of apoptosis proteins to affect apoptosis decisions after MOMP in colorectal cancer patients (d). ROC and AUC of the ability of apoptosis proteins to affect molecular timer dependency of apoptotic resistance after MOMP in colorectal cancer patients (e). P values in C by Kruskal–Wallis with Dunn’s correction.